As previously mentioned, Yoshii and Shinohara had demonstrated that PBMCs from GBS patients produce less IL-2 and have a lessened response to IL-2 compared to healthy controls (Yoshii and Shinohara, 2000). The gene discussed is IL2; the disease is Guillain-Barre syndrome.